Antibiotic-associated pseudomembranous colitis.
D000667:Ampicillin / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001414:Bacitracin / Q000627:therapeutic use; D002511:Cephalosporins / Q000009:adverse effects; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002981:Clindamycin / Q000009:adverse effects; D003015:Clostridium Infections / Q000188:drug therapy / Q000209:etiology*; D006224:Cricetinae; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced* / Q000188:drug therapy / Q000382:microbiology; D006168:Guinea Pigs; D006801:Humans; D007422:Intestines / Q000382:microbiology; D013203:Staphylococcal Infections / Q000209:etiology; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002792:Cholestyramine Resin; D001414:Bacitracin; D002981:Clindamycin; D014640:Vancomycin; D000667:Ampicillin